Table 2.
Distribution of demographic characteristics and comorbidities among the groups categorized by the different rapid test and RT-PCR result interpretation
| Parameters | BD+ (N = 47) | BD– (N = 199) | BD FP (N = 1) | BD FN (N = 13) | Standard Q+ (N = 41) | Standard Q– (N = 200) | Standard Q FP (N = 0) | Standard Q FN (N = 19) |
|---|---|---|---|---|---|---|---|---|
| Age, years | ||||||||
| Mean | 39 | 37 | 30 | 41 | 40 | 37 | – | 39 |
| Range | 18–67 | 18–81 | – | 22–74 | 18–61 | 18–81 | 22–74 | |
| Sex | ||||||||
| Male | 37 (78.72) | 129 (64.82) | 1 (100) | 7 (53.85) | 32 (78.05) | 130 (65.0) | – | 12 (63.16) |
| Female | 10 (21.28) | 70 (35.18) | – | 6 (46.15) | 9 (21.95) | 70 (35.0) | – | 7 (36.84) |
| BMI | – | – | ||||||
| Normal | 21 (44.68) | 114 (57.29) | – | 5 (38.46) | 19 (46.34) | 114 (57.0) | – | 7 (36.84) |
| Overweight | 23 (48.94) | 66 (33.17) | 1 (100) | 7 (53.45) | 20 (48.78) | 67 (33.50) | – | 10 (52.63) |
| Obese | 3 (6.38) | 18 (9.05) | – | 1 (7.69) | 2 (4.88) | 18 (9.0) | – | 2 (10.53) |
| Underweight | – | 1 (0.50) | – | – | – | 1 (0.50) | – | – |
| Comorbidities | – | |||||||
| DM | 8 (17.02) | 23 (11.56) | – | 3 (23.08) | 7 (17.07) | 23 (11.50) | – | 4 (21.05) |
| HTN | 7 (14.89) | 27 (13.57) | – | 2 (15.38) | 7 (17.07) | 27 (13.50) | – | 2 (10.53) |
| Asthma | 3 (6.38) | 9 (4.52) | – | 2 (15.38) | 2 (4.87) | 9 (4.50) | – | 3 (15.79) |
| CKD | – | 1 (0.50) | – | – | – | 1 (0.50) | – | – |
| CHD | 3 (6.38) | 5 (2.51) | – | – | 3 (7.32) | 5 (2.50) | – | – |
RT-PCR = reverse transcriptase polymerase chain reaction. BD+ = specimens positive by both BD Veritor kit and RT-PCR; BD– = specimens negative by both BD Veritor kit and RT-PCR; BD FP = false-positive result by BD Veritor kit; BD FN = false-negative result by BD Veritor kit; Standard Q+ = specimens positive by both Standard Q kit and RT-PCR; Standard Q– = specimens negative by both Standard Q kit and RT-PCR; Standard Q FP = false-positive result by Standard Q kit; Standard Q FN = false-negative result by Standard Q kit.